Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and women.

[1]  G. Musso,et al.  Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism , 2012, Hepatology.

[2]  K. Sung,et al.  Effect of Nonalcoholic Fatty Liver Disease on the Development of Type 2 Diabetes in Nonobese, Nondiabetic Korean Men , 2012, Gut and liver.

[3]  S. Wild,et al.  Combined Influence of Insulin Resistance, Overweight/Obesity, and Fatty Liver as Risk Factors for Type 2 Diabetes , 2012, Diabetes Care.

[4]  F. Agosti,et al.  Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[5]  James E. Nelson,et al.  Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease , 2012, Hepatology.

[6]  G. Cabibbo,et al.  Hyperferritinemia is a risk factor for steatosis in chronic liver disease. , 2009, World journal of gastroenterology.

[7]  S. Kahn,et al.  The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality , 2009, Diabetologia.

[8]  G. Nijpels,et al.  Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response. , 2009, Metabolism: clinical and experimental.

[9]  S. Kahn,et al.  Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels , 2009, Diabetes Care.

[10]  P. Pouwels,et al.  Lack of association of liver fat with model parameters of beta-cell function in men with impaired glucose tolerance and type 2 diabetes. , 2008, European journal of endocrinology.

[11]  C. Datz,et al.  Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. , 2008, The American journal of clinical nutrition.

[12]  D. Winge,et al.  Iron-Mediated Inhibition of Mitochondrial Manganese Uptake Mediates Mitochondrial Dysfunction in a Mouse Model of Hemochromatosis , 2008, Molecular medicine.

[13]  H. Ellingsgaard,et al.  Islet Inflammation in Type 2 Diabetes , 2008, Diabetes Care.

[14]  G. Rossi,et al.  Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003). , 2008, Diabetes Care.

[15]  Hirokazu Takahashi,et al.  High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH , 2007, Journal of Gastroenterology.

[16]  L. N. Valenti,et al.  Iron Depletion by Phlebotomy Improves Insulin Resistance in Patients With Nonalcoholic Fatty Liver Disease and Hyperferritinemia: Evidence from a Case-Control Study , 2007, The American Journal of Gastroenterology.

[17]  Z. Halpern,et al.  NAFLD and hyperinsulinemia are major determinants of serum ferritin levels. , 2007, Journal of hepatology.

[18]  B. Balkau,et al.  Ferritin and Transferrin Are Associated With Metabolic Syndrome Abnormalities and Their Change Over Time in a General Population , 2007, Diabetes Care.

[19]  M. Sandhu,et al.  Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study , 2007, Diabetologia.

[20]  S. Kahn,et al.  Review: The role of insulin resistance in nonalcoholic fatty liver disease. , 2006, The Journal of clinical endocrinology and metabolism.

[21]  A. Saraya,et al.  Oxidant Stress and Antioxidant Status Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD) , 2006, Journal of clinical gastroenterology.

[22]  D. McClain,et al.  High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis , 2006, Diabetologia.

[23]  Claudio Cobelli,et al.  Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. , 2005, Diabetes.

[24]  J. Fernández-Real,et al.  Iron stores, blood donation, and insulin sensitivity and secretion. , 2005, Clinical chemistry.

[25]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[26]  E. Çakır,et al.  Systemic Markers of Lipid Peroxidation and Antioxidants in Patients with Nonalcoholic Fatty Liver Disease , 2005, The American Journal of Gastroenterology.

[27]  R. Cooksey,et al.  Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. , 2004, Endocrinology.

[28]  E. Guallar,et al.  Serum ferritin and risk of the metabolic syndrome in U.S. adults. , 2004, Diabetes care.

[29]  J. Kench,et al.  Beyond insulin resistance in NASH: TNF‐α or adiponectin? , 2004, Hepatology.

[30]  J. Manson,et al.  Relationship of total and abdominal adiposity with CRP and IL-6 in women. , 2003, Annals of epidemiology.

[31]  L. Kuller,et al.  Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. , 2003, American journal of physiology. Endocrinology and metabolism.

[32]  J. Fernández-Real,et al.  Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. , 2002, Diabetes.

[33]  R. Stoohs,et al.  Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[34]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[35]  E. Ford,et al.  Diabetes and serum ferritin concentration among U.S. adults. , 1999, Diabetes care.

[36]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[37]  B. Zinman,et al.  Factors determining glucose tolerance in patients with thalassemia major. , 1993, The Journal of clinical endocrinology and metabolism.

[38]  Roland Bramlet,et al.  Radioactive and Stable Isotope Tracers in Biomedicine , 1993 .

[39]  C. Tiribelli,et al.  Fatty Infiltration of the Liver: Quantification by 1H Localized Magnetic Resonance Spectroscopy and Comparison with Computed Tomography , 1993, Investigative radiology.

[40]  B. Cesana,et al.  Surival and prognostic factors in 212 Italian patients with genetic hemochromatosis , 1992, Hepatology.

[41]  L. Groop,et al.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.

[42]  G. W. Snedecor.  STATISTICAL METHODS , 1967 .

[43]  K. Yarasheski,et al.  Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity. , 2011, American journal of physiology. Endocrinology and metabolism.

[44]  J. Ordovás,et al.  Nutrition, metabolism and cardiovascular disease , 2011 .

[45]  K. Kowdley,et al.  Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice , 2010, Nature Reviews Endocrinology.

[46]  R. DeFronzo,et al.  Elevated Concentrations of Liver Enzymes and Ferritin Identify a New Phenotype of Insulin Resistance: Effect of Weight Loss After Gastric Banding , 2009, Obesity surgery.

[47]  S. Kahn,et al.  An Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-Hour Glucose Levels Short title: Oral Disposition Index Predicts Diabetes , 2008 .

[48]  R. Goebbels,et al.  The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study , 2005, Diabetologia.

[49]  T. Hsiao,et al.  Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients , 2004, International Journal of Obesity.

[50]  C. McClain,et al.  LIVER DISEASE Cytokines and NASH : A Pilot Study of the Effects of Lifestyle Modification and Vitamin E , 2003 .

[51]  H. Nakamura,et al.  Thioredoxin levels in the sera of untreated viral hepatitis patients and those treated with glycyrrhizin or ursodeoxycholic acid. , 2000, Antioxidants & redox signaling.

[52]  G. Warnick.  Enzymatic methods for quantification of lipoprotein lipids. , 1986, Methods in enzymology.

[53]  Warnick Gr.  Enzymatic methods for quantification of lipoprotein lipids. , 1986 .